Pataigin Appoints Deborah Elvins as Strategic Advisor
SEATTLE, WA – 30 March, 2022 – Microbiology diagnostics company Pataigin today appointed Deborah A. Elvins as an advisor to the company on business strategy and other business …
Direct-From-Specimen Results to be Presented at ECCMID 2022 Conference
LISBON, Portugal: Results will be presented from a study of Pataigin’s rapid bacterial ID assay, direct from clinical specimens.
At the 32nd European Congress of Clinical Microbiology & …
Pataigin Introduces First Multiplex Lipid Microbiology Kit
VIENNA, Austria, BALTIMORE Maryland, and Seattle, Washington – 13 July 2021: At the 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID, www.eccmid.org), Pataigin …
Pataigin Awarded NIH Grant to Improve Antimicrobial Stewardship
Today, the US NIH awarded Pataigin a research grant to further development of Pataigin’s Rigel antimicrobial susceptibility test.
“We thank the NIH for supporting this research,” …
Archive
- March 2022
- February 2022
- January 2022
- December 2021
- July 2021
- June 2021
- March 2021
- January 2021
- December 2020
- October 2020
- September 2020
- June 2020
- October 2019
- April 2019
- February 2019
- January 2019
- October 2018
- April 2018
- November 2017
- August 2017
- July 2017
- May 2017
- October 2016
- September 2016
- December 2015
- July 2015
- October 2013
- August 2013
- May 2012
- October 2007
- July 2007
